| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 01/25/2007 | US20070021618 Crystal structure; hydrates; dissolvin gin solution; adding base; crystallization; salt formation |
| 01/25/2007 | US20070021617 Crystal structure; hydrates; dissolving in solution; adding base; crystallization; salt formation |
| 01/25/2007 | US20070021616 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 01/25/2007 | US20070021612 Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof |
| 01/25/2007 | US20070021610 Such as (R,R)-2,3-bis(tert-butylmethylphosphino)quinoxaline, by deprotonating dialkylphosphine-borane, reacting with 2,3-dihalogenopyrazine, then deboranating; storage stability; hydrogenation catalysts |
| 01/25/2007 | US20070021393 New use of GabaB receptor agonists |
| 01/25/2007 | US20070021389 polymorphs of zoledronic acid and zoledronate sodium salts; monohydrate form; inhibitor of osteoclastic bone resorption |
| 01/25/2007 | US20070021388 trans-stereochemistry to improve half life, oral bioavailability and activity; liver disorderslike liver cancer, liver infections, fibrosis, obesity; trans-4-(3-chlorophenyl)-2-(4-nitrophenoxy)-2-oxo-1,3,2-dioxaphosphorinane |
| 01/25/2007 | US20070021387 Administering a phosphate ester of florfenicol that may be hydrolyzed to form free florfenicol, e.g., 1R,2S-1-(4-Methanesulfonylphenyl)-2-(2,2-dichloroacetylamino)-3-fluoropropyl]-di-tert-butyl phosphate to treat or prevent bacterial infections |
| 01/25/2007 | US20070021367 Modulation of SOCS-3 expression |
| 01/25/2007 | US20070021362 Antisense antibacterial method and compound |
| 01/25/2007 | US20070021361 Methods and materials for modulating trpm2 |
| 01/25/2007 | US20070020679 Modulation of HIF1alpha and HIF2alpha expression |
| 01/25/2007 | US20070020675 Modulation of endothelial lipase expression |
| 01/25/2007 | US20070020185 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | US20070020184 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | DE102005037076B3 Preparation of a mixture of substituted organobismuth compound, useful as e.g. precursor for gas phase separation of bismuth containing material, comprises mixing Grignard reagent with different alkyl groups |
| 01/25/2007 | DE102005033102A1 New tantalum- or niobium compounds useful as precursors for tantalum nitride- and niobium nitride layering by means of chemical vapor deposition procedure |
| 01/25/2007 | CA2614674A1 Antiviral compounds |
| 01/25/2007 | CA2614167A1 Low-phosphorous lubricant additive |
| 01/24/2007 | EP1745114A1 Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate |
| 01/24/2007 | EP1745058A1 Cycloolefin phosphine ligands and their use in catalysis |
| 01/24/2007 | EP1745057A1 Process for the preparation of the alkoxyamine 2-methyl-2-¬n-(diethoxyphosphoryl-2,2-dimethylpropyl)-aminoxy|propionic acid |
| 01/24/2007 | EP1745056A2 Enantioselective phosphoramidite compounds and catalysts |
| 01/24/2007 | EP1472217B1 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 01/24/2007 | CN1902213A Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same |
| 01/24/2007 | CN1902212A Process to prepare alkyl phenyl phosphates |
| 01/24/2007 | CN1902199A 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity |
| 01/24/2007 | CN1902159A Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/24/2007 | CN1900094A Organic platinum new complex |
| 01/24/2007 | CN1900091A Nucleotide analog compositions |
| 01/24/2007 | CN1900090A Nucleotide analog compositions |
| 01/24/2007 | CN1900089A Nucleotide analog compositions |
| 01/24/2007 | CN1900088A Asymmetric 0-alkyl, 0'-aryl, N-substituted pyridyl methyl phosphamate and its preparing method and pesticidal activity |
| 01/24/2007 | CN1900087A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 01/24/2007 | CN1900086A Process for preparing ethyl parathion artificial semi antigen, artificial antigen, antibody and their use |
| 01/24/2007 | CN1900085A Trimethyl phosphite producing process |
| 01/24/2007 | CN1899972A Process for the preparation of a nickel/phosphorus ligand catalyst for olefin hydrocyanation |
| 01/24/2007 | CN1296376C Process for preparing PMIDA |
| 01/23/2007 | US7166744 Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds |
| 01/23/2007 | US7166737 Secondary phosphonate esters and alkene compounds are reacted in a transition metal medium; use as a carbon-carbon binding formation agent, as well as a synthesis intermediate for drugs and agrochemicals |
| 01/23/2007 | US7166736 Neopentylglycol bis(diaryl phosphate) esters |
| 01/23/2007 | US7166660 Polymer heat and stress protection; effective at low concentration; discoloration inhibition during melt processing; tert-alkyl linked aryl phosphines |
| 01/23/2007 | US7166476 Highly reproducible agglutination immunoassay method and reagents |
| 01/23/2007 | CA2378877C Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/23/2007 | CA2182987C Novel phosphoric acid-amino acid complex salt and additive composition containing the salt and used in feed for ruminant mammals |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007009109A2 Antiviral compounds |
| 01/18/2007 | WO2007009007A2 Methods of treatment using hydroquinone ansamycins |
| 01/18/2007 | WO2007006915A1 Fireproof phosphonate product and a method |
| 01/18/2007 | WO2007006648A1 (meth)acrylamide phosphorus monomer composition |
| 01/18/2007 | WO2007006387A2 Onium-alkylsulfonate production method |
| 01/18/2007 | WO2007006300A1 Production of monomer, oligomer and polymer phosphonic acid esters and phosphonic and sulphonic acids by a nucleophile aromatic substitution |
| 01/18/2007 | WO2006124713A3 4-biarylyl-1-phenylazetidin-2-ones |
| 01/18/2007 | WO2006110157A3 Nucleoside phosphonate conjugates as anti hiv agents |
| 01/18/2007 | WO2006106123A3 Improved method for producing biphenols from monophenols |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | US20070015927 New phosphoramidite compounds |
| 01/18/2007 | US20070015925 Reacting an uncharged or cationic ruthenium or iridium complex and the salt of a chiral ditertiary diphosphine with phospholane groups bound to a carbon chain, with RcCOO-, RcSO3-, BF4-, PF6-, AsF6-SbF6-, B(C6F5)4- or B(3,5-bistrifluoromethylphenyl)4- anion |
| 01/18/2007 | US20070015801 Bactericides; (5R)-(-)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxamide |
| 01/18/2007 | US20070015735 Water-dispersible carotenoids, including analogs and derivatives |
| 01/18/2007 | US20070015734 Mao-b inhibitors useful for treating obesity |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/18/2007 | US20070015731 5,6-Di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 01/18/2007 | US20070015725 2-azapurine compounds and their uses |
| 01/18/2007 | US20070015028 Proton conductor and method for manufacturing the same, and electrochemical device |
| 01/18/2007 | DE19782294B4 Nicht-Steroide Liganden für den Estrogenrezeptor Non-steroidal ligands for the estrogen receptor |
| 01/18/2007 | CA2614399A1 (meth)acrylamide phosphorus monomer composition |
| 01/18/2007 | CA2614276A1 Antiviral compounds |
| 01/18/2007 | CA2612506A1 Methods of treatment using hydroquinone ansamycins |
| 01/17/2007 | EP1744598A1 Organic electroluminescent element and manufacturing method thereof, organic compound containing phosphorus and manufacturing method thereof |
| 01/17/2007 | EP1743899A1 Metal complexes for use in metathesis, atom transfer radical reactions, addition polymerisation and vinylation reactions, methods and intermediates for making them |
| 01/17/2007 | EP1742992A2 Metal phosphonates and related nanocomposites |
| 01/17/2007 | EP1742911A1 3,4-disubstituted maleimides for use as vascular damaging agents |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
| 01/17/2007 | EP1694623A4 Practical, cost-effective synthesis of ubiquinones |
| 01/17/2007 | EP1567535B1 Bidentate c,p chiral phosphine ligands |
| 01/17/2007 | CN1898256A Method for producing organoacylphosphites |
| 01/17/2007 | CN1898255A Process for the preparation of pyridine derivatives |
| 01/17/2007 | CN1898254A New coupling agents for peptide synthesis |
| 01/17/2007 | CN1898253A Method for producing trivalent organophosphorus compounds |
| 01/17/2007 | CN1898245A Process for the preparation of triazolopyrimidines |
| 01/17/2007 | CN1898238A Oxazolidinone-quinolone hybrid antibiotics |
| 01/17/2007 | CN1897954A Florfenicol prodrug having improved water solubility |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1896085A Synthesis of recyclable chiral metathesis catalysts |
| 01/17/2007 | CN1896084A Non-sedating barbituric acid derivatives |
| 01/17/2007 | CN1896083A Macromolecular polyacyl phosphine imide light initiating agent and its production |
| 01/17/2007 | CN1896082A Phosphate dispersant, paste composition and dispersion method using the same |
| 01/17/2007 | CN1896042A Production of hair orchid |
| 01/17/2007 | CN1295684C Lubricant for magnetic recording medium and use thereof |
| 01/17/2007 | CN1295236C Process for manufacturing alkylphosphonate monoesters |
| 01/16/2007 | US7164045 Combining epoxide with aqueous hydrobromic acid to form a bromohydrin, isolating bromohydrin and removing water, combining dried bromohydrin with n-butyl lithium, wherein molar ratio of n-butyl lithium to bromohydrin is 2, adding chlorophosphine to above product and adding acid to product |
| 01/16/2007 | US7164016 Complex containing radioactive material; medical diagnosis of tumor |
| 01/16/2007 | US7164014 Used to produce amino- modified linkers that space an oligonucleotide from a solid support |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |